Galecto Inc
NASDAQ:GLTO

Watchlist Manager
Galecto Inc Logo
Galecto Inc
NASDAQ:GLTO
Watchlist
Price: 0.6211 USD -1.41% Market Closed
Updated: May 20, 2024

Galecto Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Galecto Inc
Accrued Liabilities Peer Comparison

Comparables:
GMAB
ZEAL
ASND
B
BAVA
BIOPOR

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Galecto Inc
NASDAQ:GLTO
Accrued Liabilities
$2.9m
CAGR 3-Years
28%
CAGR 5-Years
71%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Accrued Liabilities
kr51.7m
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Accrued Liabilities
kr308.5m
CAGR 3-Years
38%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Accrued Liabilities
kr16.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Galecto Inc's Accrued Liabilities?
Accrued Liabilities
2.9m USD

Based on the financial report for Dec 31, 2023, Galecto Inc's Accrued Liabilities amounts to 2.9m USD.

What is Galecto Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
71%

Over the last year, the Accrued Liabilities growth was 164%. The average annual Accrued Liabilities growth rates for Galecto Inc have been 28% over the past three years , 71% over the past five years .